NCT03692806View on ClinicalTrials.gov

Efficacy of STABLOR® on Visceral Fat Mass Reduction in Patients With Metabolic Syndrome

NACompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

September 11, 2018

Primary Completion Date

October 31, 2019

Study Completion Date

December 16, 2020

Conditions
Metabolic Syndrome
Interventions
DIETARY_SUPPLEMENT

Stablor

Stablor sachet

DIETARY_SUPPLEMENT

placebo

placebo sachet

Trial Locations (6)

21000

CEN Experimental, Dijon

38610

Eurofins Optimed, Gières

44800

Biofortis, Saint-Herblain

59019

Institut Pasteur de Lille, Lille

75651

CIC Pitié Salpêtrière, Paris

Unknown

Atlantia Food Clinical Trials, Cork

Sponsors

Lead Sponsor

LNC THERAPEUTICS
All Listed Sponsors
collaborator

Biofortis Mérieux NutriSciences

OTHER

collaborator

StatistiCal BV Wassenarr, The Netherland represented by Dr W.Calame

UNKNOWN

lead

LNC THERAPEUTICS

INDUSTRY